pharma · Acne Rosacea · Atopic Dermatitis · DRMA
Dermata Therapeutics
Dermata Therapeutics is a pharma organization headquartered in San Diego, USA. It trades on NYSE under ticker DRMA. Primary therapeutic focus areas include Acne Rosacea, Atopic Dermatitis, Acne Vulgaris. NovaPharmaNews l
San Diego, USA HQ
2014 Founded
12 Employees
Public company Type
DRMA · NYSE Ticker
Company details
- Status
- Public
- HQ
- San Diego, USA
- Founded
- 2014
- Employees
- 12
- Programs
- 4
- Drugs
- 2
- Patents
- 30
DMT310
Phase 3 · small molecule · Acne Vulgaris
DMT310 for Acne Vulgaris is a Phase 3 program (small_molecule) at Dermata Therapeutics with 3 ClinicalTrials.gov record(s).
Internal code DMT310-009
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Dermata Therapeutics
- Phase
- Phase 3
- Modality
- small_molecule
- Indication
- Acne Vulgaris
- Status
- completed
- Trials
- 3